Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|May 21, 2024
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming OpportunitiesKristen Feemster, Ulrike K Buchwald, Natalie Banniettis, et al.
Pediatric Dermatology|October 20, 2018
Infective dermatitis associated with HTLV-1 infection in a girl from Trinidad: Case report and review of literatureNicole Weiler, Erick F Mayer, Viktoryia Kazlouskaya, et al.
Human Vaccines & Immunotherapeutics|September 2, 2021
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adultsErin M Paradis, Oleg Tikhonov, Xin Cao, et al.
Expert Review of Vaccines|October 17, 2023
An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infantsShahrul Mt-Isa, Justin R Chumbley, Emma L Crawford, et al.
Vaccines|September 28, 2024
Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in GermanyMin Huang, Jessica P Weaver, Elamin Elbasha, et al.
Infectious Diseases and Therapy|March 19, 2025
PCV13-Serotype Breakthrough Pneumococcal Disease in Infants Receiving High-Valency Conjugate Vaccines: Population-Level Modeling in FranceKevin M Bakker, Rachel J Oidtman, Natalie Banniettis, et al.
Open Forum Infectious Diseases|June 8, 2018
Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases PhysiciansNatalie Banniettis, Susan E Beekmann, Philip M Polgreen, et al.
Human Vaccines & Immunotherapeutics|August 2, 2023
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6CYaru Shi, Katrina M Nolan, Robert L Burton, et al.
Expert Review of Vaccines|December 19, 2023
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and childrenTimothy J Chapman, Liset Olarte, Ghassan Dbaibo, et al.
Vaccines|June 27, 2025
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination ScheduleRachel J Oidtman, Natalie Banniettis, Jessica Weaver, et al.
Pageof 4